Office‐based vergence and anti‐suppression therapy for the treatment of small‐to‐moderate angle intermittent exotropia: A randomised clinical trial.

MLA

Ma, Martin Ming‐Leung, et al. “Office‐based Vergence and Anti‐suppression Therapy for the Treatment of Small‐to‐moderate Angle Intermittent Exotropia: A Randomised Clinical Trial.” Ophthalmic & Physiological Optics, vol. 44, no. 2, Mar. 2024, pp. 356–77. EBSCOhost, https://doi.org/10.1111/opo.13264.

APA

Ma, M. M., Kang, Y., Scheiman, M., Chen, Q., Ye, X., Pan, L., Deng, J., Su, G., Zhang, G., & Chen, X. (2024). Office‐based vergence and anti‐suppression therapy for the treatment of small‐to‐moderate angle intermittent exotropia: A randomised clinical trial. Ophthalmic & Physiological Optics, 44(2), 356–377. https://doi.org/10.1111/opo.13264

Chicago

Ma, Martin Ming‐Leung, Ying Kang, Mitchell Scheiman, Qiwen Chen, Xuelian Ye, Liuqing Pan, Jiayu Deng, Guangxing Su, Guohui Zhang, and Xiang Chen. 2024. “Office‐based Vergence and Anti‐suppression Therapy for the Treatment of Small‐to‐moderate Angle Intermittent Exotropia: A Randomised Clinical Trial.” Ophthalmic & Physiological Optics 44 (2): 356–77. doi:10.1111/opo.13264.